International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 8,262 shares.
International Stem Cell Price Performance
The firm has a market cap of $930,400.00, a price-to-earnings ratio of -1.45 and a beta of 0.30. The firm has a fifty day simple moving average of $0.10 and a two-hundred day simple moving average of $0.08.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- Business Services Stocks Investing
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- With Risk Tolerance, One Size Does Not Fit All
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 10 Best Airline Stocks to Buy
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
